Old Web
English
Sign In
Acemap
>
authorDetail
>
Gary V. H. Dahl
Gary V. H. Dahl
Children's Oncology Group
Medicine
Oncology
Internal medicine
Pathology
Core binding factor
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
cooperative trials for de novo AML patients with core binding factor AML enrolled on serial pediatric mutations in pediatric KIT Prevalence and prognostic significance of
2011
Robert J. Arceci
Jerald P. Radich
Irwin D. Bernstein
Michael Heinrich
Susana C. Raimondi
Nyla A. Heerema
William G. Woods
Beverly J. Lange
Gary V. H. Dahl
Norman J. Lacayo
David L. Becton
Myron Chang
Howard J. Weinstein
Jessica A. Pollard
Todd A. Alonzo
Robert B. Gerbing
Phoenix A. Ho
Rong Zeng
Show All
Source
Cite
Save
Citations (0)
Single Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Pediatric Patients with De Novo Acute Myeloid Leukemia (AML): Validation Study Results,
2011
Blood
Norman J. Lacayo
Todd A. Alonzo
Urte Gayko
Matt Westfall
Norman Purvis
Santosh Putta
James Hackett
Aileen Cohen
Robert B. Gerbing
Gary V. H. Dahl
Alan S. Gamis
Soheil Meshinchi
Show All
Source
Cite
Save
Citations (2)
children with AML in remission: Pediatric Oncology Group Study 9421 Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in
2010
Howard J. Weinstein
David R. Head
Kimo C. Stine
Norman J. Lacayo
Branimir I. Sikic
Robert J. Arceci
David L. Becton
Gary V. H. Dahl
Yaddanapudi Ravindranath
Myron Chang
Frederick G. Behm
Show All
Source
Cite
Save
Citations (0)
1